649 Views

Instructional Course

Instructional Course - Available with the Platinum and Silver packages or Individual Course Ticket

053IC - Difficult Cases in High-Risk Bladder Cancer: An Evidence-Based Approach

Saturday, May 14, 2022

7:30 AM – 9:30 AM

Location: Room 208

Instructional Course Director(s)

Michael S. Cookson, MD,MHA

Professor and Chair
University of Oklahoma

Instructional Course Faculty(s)

sanjay Patel, MD

Associate Professor
University of Oklahoma Health Sciences Center
jH

jeff M. Holzbeierlein, MD

Physician in Chief
University of Kansas Health System
Timothy A. Masterson, MD,FACS (he/him/his)

Professor of Urology
Indiana University School of Medicine

Learning Objectives:

Identify low, intermediate and high risk non-muscle invasive bladder cancer (NMIBC)
Recommend treatment for NMIBC based on risk stratification.
Identify bacillus Calmette-Guérin (BCG) unresponsive NMIBC and novel immune-based strategies and intravesical therapies.
Manage invasive bladder cancer including surgery, neoadjuvant and adjuvant chemotherapy and bladder preservation strategies in patients with muscle invasive bladder cancer. This will include chemotherapy indications and the role of immunotherapy in the management.
Manage upper tract tumors, both low grade and high grade, including renal preservation when appropriate, neoadjuvant therapy when indicated and surgical management strategies.

The course director will select 6 real cases from his own practice that represent challenging cases in
bladder cancer and present them to his panelists. The panelists will review the available literature and
formulate a treatment plan based upon the guidelines and published literature. The course director will
then present the actual patient outcome and readdress the panelists with follow-up problems and
questions to illustrate the many unique aspects of dealing with these patients.